Validation of a model of lung cancer risk prediction among smokers

Journal of the National Cancer Institute

Volumn 98, Issue 9, 2006, Pages 637-640

  Cronin, Kathleen A ^a,e   Gail, Mitchell H ^a   Zou, Zhaohui ^b   Bach, Peter B ^c   Virtamo, Jarmo ^d   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e Statistical Research and Applications Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; PLACEBO; RETINOL; ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROCESS MODEL; RISK ASSESSMENT; SMOKING HABIT; THORAX RADIOGRAPHY; VALIDATION PROCESS; AGE DISTRIBUTION; INCIDENCE; LUNG TUMOR; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; RADIOGRAPHY; REPRODUCIBILITY; RISK FACTOR; SMOKING; STATISTICAL MODEL; UNITED STATES;

AGE DISTRIBUTION; AGE FACTORS; AGED; ALPHA-TOCOPHEROL; ANTICARCINOGENIC AGENTS; BETA CAROTENE; CLINICAL TRIALS; CONFIDENCE INTERVALS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MASS CHEST X-RAY; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SMOKING; UNITED STATES;

EID: 33646441763     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj163     Document Type: Article

References (10)

1. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8.
2. Omenn GS, Goodman PC, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Res 1994; 54(7 Suppl):2038s-43s.
3. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 1996;334:1150-5.
4. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et al. α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
5. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparameteric approach. Biometrics 1988;44:837-45.
6. Fontana, RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, et al. Screening for lung cancer: A critique of the Mayo Lung Project. Cancer 1991;67:1155-64.
7. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-66.
8. Bach PB, Kelley MJ, Tate RC, McCrory DC. Screening for lung cancer: A review of the current literature. Chest 2003;123: 72s-82s.
9. Gail MH, Pfeiffer RM. On criteria for evaluating models of absolute risk. Biostatistics 2005;6:227-39.
10. Rockhill B, Byrne C, Rosner B, Louie MM, Colditz G. Breast cancer risk prediction with a log-incidence model: Evaluation of accuracy. J Clin Epidemiol 2003;56:856-61.